服務範疇
- 哮喘 / 氣管敏感
- 慢性阻塞性肺疾病 (COPD)
- 感染性肺炎
- 肺結節/肺部陰影
- 肺结核
- 縱隔疾病
- 肺癌
- 睡眠窒息症
- 間質性肺疾病
- 胸膜疾病 (胸腔積液 / 氣胸)
- 治療性支氣管鏡檢查
- 診斷性支氣管鏡檢查
- 呼吸衰竭
出版物
- Kwok, W. C., Chau, C. H., Tam, T. C. C., Lam, F. M., & Ho, J. C. M. (2023). Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease, 18, 1145–1153.
- Kwok, W. C., Tam, T. C. C., Lam, D. C. L., Ip, M. S. M., & Ho, J. C. M. (2023). Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis. The clinical respiratory journal, 17(6), 548–555.
- Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong. Pharmacoepidemiology and drug safety, 1-6.
- Kwok, W. C., Ma, T. F., Ho, J. C. M., Lam, D. C. L., Sit, K. Y., Ip, M. S. M., Au, T. W. K., & Tam, T. C. C. (2023). Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology (Carlton, Vic.), 28(7), 669–676
- Kwok, W. C., Tam, T. C. C., Sing, C. W., Chan, E. W. Y., & Cheung, C. L. (2023). Validation of Diagnostic Coding for Asthma in an Electronic Health Record System in Hong Kong. Journal of asthma and allergy, 16, 315–321.
- Kwok, W. C., Tsoi, M. F., Leung, S. H. I., Tsui, C. K., Tam, T. C. C., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Ho, P. L. (2023). Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting. Viruses, 15(3), 610.
- Kwok, W. C., Tam, T. C. C., Lam, D. C. L., Leung, J. K. C., Chan, K. P. F., Chan, S. K. S., Chiang, K. Y., Ip, M. S. M., & Ho, J. C. M. (2023). Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respiratory research, 24(1), 53.
- Kwok, W. C., Leung, S. H. I., Tam, T. C. C., Ho, J. C. M., Lam, D. C., Ip, M. S. M., & Ho, P. L. (2023). Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases. International journal of chronic obstructive pulmonary disease, 18, 47–56.
- Zouari, F., Oon, W. Y., Modak, D., Lee, W. H., Kwok, W. C., Cao, P., Lee, W. N., Tam, T. C. C., Wong, E. C., & Chan, R. W. (2022). Affordable, portable and self-administrable electrical impedance tomography enables global and regional lung function assessment. Scientific reports, 12(1), 20613.
- Zouari, F., Oon, W. Y., Modak, D., Kwok, W. C., Cao, P., Lee, W. N., Tam, T. C. C., Wong, E. C., & Chan, R. W. (2022). Standalone electrical impedance tomography predicts spirometry indicators and enables regional lung assessment. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2022, 3277–3280.
- Duan, J., Tan, F., Bi, N., Chen, C., Chen, K. N., Cheng, Y., Chu, Q., Ge, D., Hu, J., Huang, Y., Jiang, T., Long, H., Lu, Y., Shi, M., Wang, J., Wang, Q., Yang, F., Yang, N., Yao, Y., Ying, J., … Gao, S. (2022). Expert consensus on perioperative treatment for non-small cell lung cancer. Translational lung cancer research, 11(7), 1247–1267.
- Kwok, W. C., Lam, D. C. L., Ip, M. S. M., Tam, T. C. C., & Ho, J. C. M. (2022). Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities. Anti-cancer drugs, 33(10), 1139–1144.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2022). Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use. Journal of thoracic disease, 14(6), 1880–1889.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2022). Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first-line setting. Thoracic cancer, 13(14), 2057–2063.
- Kwok, W. C., Cheong, T. F., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2023). Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non-small cell carcinoma. Asia-Pacific journal of clinical oncology, 19(1), 87–95.
- Wang, A., Tam, T. C. C., Poon, H. M., Yu, K.-C., and Lee, W.-N., “NaviAirway: a Bronchiole-sensitive Deep Learning-based Airway Segmentation Pipeline”, <i>arXiv e-prints</i>, 2022.
- Kwok, W. C., Tam, A. R., Ho, J. C. M., Lam, D. C. L., Tam, T. C. C., Chan, K. P. F., Wang, J. K. L., Ip, M. S. M., & Hung, I. F. N. (2022). Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19). The clinical respiratory journal, 16(4), 293–300.
- Chi-Chun Tam, T., & Chung-Man Ho, J. (2021). Navigational bronchoscopy: we should choose to do it not because it´s easy, but because it´s hard. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(1), 1–2.
- Kwok, W. C., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2021). Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung. Lung cancer (Amsterdam, Netherlands), 162, 169–174.
- Kwok, W. C., Wong, C. K., Ma, T. F., Ho, K. W., Fan, L. W., Chan, K. F., Chan, S. S., Tam, T. C., & Ho, P. L. (2021). Modelling the impact of travel restrictions on COVID-19 cases in Hong Kong in early 2020. BMC public health, 21(1), 1878.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Ip, M. S. M., & Lam, D. C. L. (2021). Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respiratory research, 22(1), 132.
- Chan, K. F., Kwok, W. C., Ma, T. F., Hui, C. H., Tam, T. C., Wang, J. K., Ho, J. C., Lam, D. C., Sau-Man Ip, M., & Ho, P. L. (2021). Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic. Annals of the American Thoracic Society, 18(10), 1624–1633.
- Kwok, W. C., Cheong, T. F., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Ip, M. S. M., & Tam, T. C. C. (2021). Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung cancer (Amsterdam, Netherlands), 152, 15–20.
- Zeng, Z., Yan, B., Chen, Y., Zhang, L., Zhu, J., Yang, F., Wei, F., Tam, T. C. C., Kauffmann-Guerrero, D., Soo, R. A., Ren, X., & You, J. (2020). Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study. Translational lung cancer research, 9(6), 2401–2410.
- Kwok, C. W., Ho, J. C. M., Lam, D. C. L. , Sze M. L. M., Ip, M. S. M.and Tam, T. C. C. *, Clinical Impact of Gastric Acid Suppressants Use on the Efficacy of Gefitinib in Patients with Advanced Adenocarcinoma of the Lung Harboring Common EGFR Mutations, Clinical Cancer Drugs 2020; 7: 57
- Kwok, W. C., Lam, D. C. L., Chiang, K. Y., Ho, J. C. M., Ip, M. S. M., & Tam, T. C. C. (2020). Real world experience on maintenance chemotherapy with gemcitabine in second line setting for advanced non-small cell lung carcinoma. Journal of chemotherapy (Florence, Italy), 32(8), 429–436.
- Tam T. (2020). Adjuvant EGFR-TKIs-based therapy: are we ready?. Translational lung cancer research, 9(4), 948–950.
- Chan, K. P. F., Ma, T. F., Kwok, W. C., Leung, J. K. C., Chiang, K. Y., Ho, J. C. M., Lam, D. C. L., Tam, T. C. C., Ip, M. S. M., & Ho, P. L. (2020). Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respiratory medicine, 171, 106085.
- Chiang, K. Y., Ho, J. C., Chong, P., Tam, T. C., Lam, D. C., Ip, M. S., Lee, Y. G., & Lui, M. M. (2020). Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer. Respirology (Carlton, Vic.), 25(11), 1167–1173.
- Kwok, W. C., Ho, J. C. M., Lam, D. C. L., Lui, M. M. S., Ip, M. S. M., & Tam, T. C. C. (2021). When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival. Asia-Pacific journal of clinical oncology, 17(2), e35–e39.
- Kwok, W. C., Ho, J. C. M., Tam, T. C. C., Lui, M. M. S., Ip, M. S. M., & Lam, D. C. L. (2019). Efficacy of gefitinib at reduced dose in EGFR mutant non-small cell lung carcinoma. Anti-cancer drugs, 30(10), 1048–1051.
- Kwok, W. C., Cheng, K. C., Lam, D. C. L., & Tam, T. C. C. (2019). First successful case of chemical pleurodesis with oxytetracycline through Rocket® Pleural Vent™: ambulatory pneumothorax device for pneumothorax. Respirology case reports, 7(7), e00471.
- Kwok, W. C., Liang, B. M., Lui, M. M. S., Tam, T. C. C., Sim, J. P. Y., Tse, E. W. C., Leung, A. Y. H., Kwong, Y. L., Lie, A. K. W., Ip, M. S. M., & Lam, D. C. L. (2019). Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome. Respirology (Carlton, Vic.), 24(5), 459–466.
- Kwok, W. C., Tam, T. C. C., & Lam, D. C. L. (2018). First reported case of afatinib-associated toxic megacolon. Respirology case reports, 6(7), e00360.
- Kwok, W. C., Tam, T. C. C., Chi Leung Lam, D., Ip, M. S. M., & Lui, M. M. S. (2018). Pulmonary embolism developing after therapeutic drainage of malignant pleural effusions. Respiratory medicine case reports, 25, 122–123.
- Terence Tam. Use of the New Veran Always-On Tip Tracked Sensor with Olympus GuideSheath System to Arrive at a Small Peripheral Ground-Glass Nodule. CHEST Volume 152, Issue 4, Supplement, Pages A641–A642
- Kwok, W. C., Tam, T. C., Lui, M. M., Lam, D. C., & Ho, J. C. (2017). Control of brain metastases with alectinib in anaplastic lymphoma kinase-rearranged lung cancer. Respirology case reports, 5(3), e00224.
- Lam, J. C. M., Lai, A. Y. K., Tam, T. C. C., Yuen, M. M. A., Lam, K. S. L., & Ip, M. S. M. (2017). CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep & breathing = Schlaf & Atmung, 21(2), 377–386.
- Wong, W. M., Tam, T. C., Wong, M. K., Lui, M. M., Ip, M. S., & Lam, D. C. (2016). Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis. Hong Kong medical journal = Xianggang yi xue za zhi, 22(4), 334–340.
- Lam, D. C., Tam, T. C., Lau, K. M., Wong, W. M., Hui, C. K., Lam, J. C., Wang, J. K., Lui, M. M., Ho, J. C., & Ip, M. S. (2015). Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer. Clinical lung cancer, 16(6), 507–513.
- Ho, J. C., Tam, T. C., & Lam, S. K. (2013). Salvage therapy beyond targeted therapy in lung adenocarcinoma. Seminars in respiratory and critical care medicine, 34(6), 837–844.
- Ho, Tam, Lam, 2013. Personalized Treatment of Lung Adenocarcinoma, Clinical Pulmonary Medicine, 20(6), 309-314.
- Tam, T. C., Ho, J. C., Wong, M. K., Wong, W. M., Wang, J. K., Lam, J. C., Lui, M. M., Lam, W. K., Ip, M. S., & Lam, D. C. (2013). Treatment outcomes in elderly with advanced-stage non-small cell lung cancer. Lung, 191(6), 645–654.
- Wong, M. K., Ho, J. C., Loong, F., Lam, D. C., Wong, W. M., Tam, T. C., Han, L., & Ip, M. S. (2013). Endobronchial ultrasound-guided transbronchial needle aspiration in lung cancer: the first experience in Hong Kong. Hong Kong medical journal = Xianggang yi xue za zhi, 19(1), 20–26.
- Wong, M. K., Tam, T. C., Lam, D. C., Ip, M. S., & Ho, J. C. (2012). EBUS-TBNA in patients presented with superior vena cava syndrome. Lung cancer (Amsterdam, Netherlands), 77(2), 277–280.
- Tam, T. C., Chan, K. Y., Ho, S. L., Luk, J. K., & Chu, L. W. (2005). Herpetic shoulder paresis in a Chinese elderly patient. Hong Kong medical journal = Xianggang yi xue za zhi, 11(5), 399–402.
傳媒專訪
相關服務
先進診斷性支氣管鏡檢查
呼吸系統科
先進診斷性支氣管鏡診斷是一種能夠對肺部疾病進行診斷和分期的微創檢查。服務包括支氣管內超聲檢查 (EBUS)、虛擬支氣管導航 (VBN)、電磁導航支氣管鏡檢查 (ENB)、動態掃描引導支氣管鏡檢查等。
顯示詳情
哮喘
呼吸系統科
一種慢性呼吸系統疾病,表現為氣喘、呼吸困難、胸悶等,需長期治療和控制。
顯示詳情
間質性肺病
呼吸系統科心胸肺外科
間質性肺病是一組影響肺間質(肺泡壁及其周圍組織)的疾病,主要特徵是肺部組織炎症和纖維化,導致氣體交換障礙。
顯示詳情
肺癌
臨床腫瘤科外科呼吸系統科心胸肺外科
肺癌是一種惡性腫瘤,常見於長期吸菸、空氣污染等因素,需早期發現和治療。
顯示詳情
肺結節
呼吸系統科心胸肺外科
肺結節可能是由炎症或良性增生等非癌症疾病引起,但也可能是癌症的早期表徵。
顯示詳情
縱隔疾病
呼吸系統科心胸肺外科
縱隔疾病的可能病因包括淋巴結腫脹大(由受感染、發炎、自體免疫性疾病或惡性腫瘤等因素引起)、胸腺瘤、膿腫、惡性腫瘤、主動脈瘤或食道疾病等。
顯示詳情
胸腔積液 (肺積水)
呼吸系統科心胸肺外科
胸腔積液 (又稱肺積水),是胸膜疾病的一種,指胸膜腔內液體異常積聚。正常情況下胸膜腔內僅有少量液體 (10-20毫升) 以潤滑胸膜運動。當液體量增加,可能壓迫肺組織,可導致呼吸困難、胸痛及其他呼吸系統症狀,需及時診斷與治療。
顯示詳情
肺炎 / 肺結核
呼吸系統科
肺炎是一種可能由細菌、病毒或其他病原體引起的肺部感染,肺結核病(俗稱肺癆)則是一種可以通過感染者咳嗽或打噴嚏時釋放的微小飛沫傳播的肺部感染,兩者初期症狀十分相似。
顯示詳情
呼吸衰竭
呼吸系統科心胸肺外科
當肺部無法充分履行為身體提供氧氣和排出二氧化碳的基本功能時,就會出現呼吸衰竭。導致呼吸衰竭的原因有很多,例如肺部疾病、細菌感染、外傷甚至某些藥物傷害等。
顯示詳情
睡眠窒息症
耳鼻喉科呼吸系統科
睡眠窒息症是一種常見的睡眠呼吸暫停症,表現為打鼾、呼吸暫停等,需注意治療和生活習慣改善。
顯示詳情
治療性支氣管鏡檢查
呼吸系統科
治療性支氣管鏡檢查是一種微創手術/程序,利用幼細而有彈性的軟性支氣管鏡,診斷和治療呼吸系統疾病。
顯示詳情
上呼吸道感染
家庭醫學呼吸系統科
由病毒或細菌引起的呼吸系統疾病,常見病徵包括發燒、喉嚨痛、流鼻水等,一般在三星期內會自然痊癒。
顯示詳情